Fig. 3From: Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemiaThe Kaplan–Meier plot of cardiovascular outcomes in patients with HeFH. A The cumulative event-free survival analysis in patients with and without physical signs (TX/CA); B the cumulative event-free survival analysis among four mutation subgroups (group1: TX/CA(−), Mu(−); group2: TX/CA(−), Mu(+); group3: TX/CA(+), Mu(−); group4: TX/CA(+), Mu(+)). TX: tendon xanthomas; CA: corneal arcus; Mu: mutation; Mu(+): mutation positive; Mu(−): mutation negativeBack to article page